Matthew Daniels,
Wellcome Trust Intermediate Clinical Fellow, Honorary Consultant Cardiologist
Matthew is an academic cardiologist currently supported by the Wellcome Trust to develop iPS models of inherited human heart disease and better ways to study them at the University of Oxford, UK. While enrolled on the Astra-Zeneca funded MB-PhD program at the University of Cambridge he developed an interest in live cell imaging and fluorescent protein technology, enabling the first observation of failure of cytokinesis causing aneuploidy in inherited human cancer (Daniels et al, Science, 2004, 306, 876-9). He then went on to train in clinical cardiology developing an internationally recognised practice in structural intervention and inherited cardiac conditions. His academic activity is currently focused on development and application of genetically encoded tools to study excitable cells, improving how these platforms can be used for rare disease drug discovery and toxicology evaluation. His career aim is to develop cell based repair of the human heart using percutaneous intracardiac devices to carry cells to the site of repair.
|
|
|
